Sarepta CEO: ‘We Have, I Believe, a Very Laudable History of Being Extraordinarily Transparent’

Sarepta Therapeutics knew about the death of a patient treated with its experimental gene therapy for a type of limb-girdle muscular dystrophy, but said nothing public for a month. Financial analysts lambasted Sarepta executives for failing to disclose the fatality when the company announced a restructuring that includes stopping work on this limb-girdle program. The…

Read More

American Heart Association Backs Auxira Health to Alleviate Cardiologist Burnout

The American Heart Association’s venture arm invested in Auxira Health, a startup that embeds virtual clinical teams into cardiology practices to reduce physician burnout and expand patient access. By handling routine tasks like follow-up visits and medication refills, Auxira gives cardiologists the opportunity to focus on complex care without adding full-time staff. The post American…

Read More

Insurers’ Preliminary Rate Filings Anticipate Biggest Increases in ACA Marketplace Plan Premiums Since 2018

This analysis of preliminary rate filings submitted by 105 ACA Marketplace insurers in 19 states and DC shows that ACA Marketplace insurers are requesting a median premium increase of 15% for 2026, which would represent the largest hike in premiums since 2018, the last time policy uncertainty contributed to sharp premium growth. The scheduled expiration…

Read More